The University of Chicago Header Logo

Connection

Steffen Sammet to Carcinoma, Medullary

Back to Details
This is a "connection" page, showing publications Steffen Sammet has written about Carcinoma, Medullary.
Steffen Sammet
Connection Strength
0.090
Carcinoma, Medullary
  1. Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol. 2010 May 10; 28(14):2323-30.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.